MIR8075

Across TCGA pan-cancer cohorts, MIR8075 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR8075 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR8075 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8075 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

LUAD, OV, and SKCM are the cancer types where MIR8075 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	108	view →
OV	OS	Tertile	All	1.000	0.835	.042	12	view →
SKCM	DFS	Tertile	All	0.226	0.757	.037	9	view →
STAD	DFS	Tertile	III,IV	0.409	0.606	.022	9	view →
READ	OS	Tertile	II,III,IV	0.461	0.746	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR8075–LUAD (DFS)

Open the LUAD breakdown →